Filing Details

Accession Number:
0001877589-24-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-03 16:19:22
Reporting Period:
2024-05-01
Accepted Time:
2024-05-03 16:19:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877589 Eli Samaha 150 East 58Th St
Ste 1403
New York NY 10155
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Com Acquisiton 2024-05-01 999,800 $8.75 8,012,026 No 4 P Indirect See Footnote
Com Acquisiton 2024-05-01 499,324 $8.75 8,511,350 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Footnotes
  1. These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.